LLY vs MMS · P/E 39, rev $22.97B vs P/E 8.1, rev $5.43B
Eli Lilly and Company (LLY) versus Maximus Inc (MMS) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Maximus Inc (MMS) is a specialty business services company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported MMS revenue for 2025-09-30 was $5.43B. Net income was $319.0M. MMS currently screens at market cap $2.82B and trailing P/E 8.1.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MMS currently screens at market cap $2.82B and trailing P/E 8.1.
Not investment advice. Open the LLY and MMS stock pages for the full models.
Not investment advice.